Verallo, Merlyn M.
HRN: 07-08-31 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2024
CEFTRIAXONE 1G (VIAL)
03/01/2024
03/08/2024
IV
2gms
OD
Pneumonia
Waiting Final Action
03/01/2024
CEFTRIAXONE 1G (VIAL)
03/01/2024
03/08/2024
IV
2gms
OD
Pneumonia
Waiting Final Action